Article references (17 references )


  1. Weinstein S, Buckwalter J. Turek's orthopaedics principles and their applications-6th ed, Philadelphia. Lipincott. 2005. Google Scholar

  2. Legeai-Mallet L, Margaritte-Jeannin P, Lemdani M, Merrer ML, Plauchu H, Maroteaux P et al. An extension of the admixture test for the study of genetic heterogeneity in hereditary multiple exostoses. Hum Genet. 1997; 99(3): 298-302. PubMed | Google Scholar

  3. Duncan G, McCormick C, Tufaro F. The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins. J Clin Invest. 2001; 108(4): 511-516. PubMed | Google Scholar

  4. Porter DE, Lonie L, Fraser M, Dobson-Stone C, Porter JR, Monaco AP et al. Severity of disease and risk of malignant change in hereditary multiple exostoses: a genotype-phenotype study. J Bone Joint Surg Br. 2004; 86(7): 1041-1046. PubMed | Google Scholar

  5. Shapiro F, Simon S, Glimcher MJ. Hereditary multiple exostoses: anthropometric, roentgenographic and clinical aspects. J Bone Joint Surg Am. 1979; 61(6A): 815-824. PubMed | Google Scholar

  6. Ochsner PE. Multiple cartilaginous exostoses and neoplastic degeneration: review of the literature. Z Orthop Ihre Grenzgeb. 1978; 116(3): 369-378. PubMed | Google Scholar

  7. Tonni DG, Ferrari B, Defelice C, Centini G. Neonatal porencephaly in very low birth weight infants: Ultrasound timing of asphyxial injury and neurodevelopmental outcome at two years of age. The Journal of Maternal-Fetal & Neonatal Medicine. 2005; 18(6): 361-365. Google Scholar

  8. Yoneda Y, Haginoya K, Arai H, Yamaoka S, Tsurusaki Y, Doi H et al. De novo and inherited mutations in COL4A2, encoding the type IV collagen α2 chain cause porencephaly. Am J Hum Genet. 2012; 90(1): 86-90. PubMed | Google Scholar

  9. Yinusa W, Owoola AM, Esin IA. Hereditary multiple exostosis: case report. Niger J Clin-Pract. 2010; 13(2): 218-222.

  10. Adelowo O, Adebayo S. Hereditary multiple exostosis in two Nigerian siblings. BMJ Case Rep. 2009; 2009: bcr09.2008.0901. Epub 2009 Apr 7. PubMed | Google Scholar

  11. Eke GK, Omunakwe HE, Echem RC. Hereditary multiple exostoses in a 15 year old boy: a case report and review of literature. Niger J Paediatr. 2016; 43(4): 295-298. Google Scholar

  12. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science. 1996; 273(5275): 613-622. PubMed | Google Scholar

  13. Thomas L. Genetic mutation predisposes to porencephaly. Lancet Neurol. 2005; 4(7): 400. PubMed | Google Scholar

  14. Mundhenke C, Meyer K, Drew S, Friedl A. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol. 2002; 160(1): 185-194. PubMed | Google Scholar

  15. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A. 1986; 83(19): 7297-7301. PubMed | Google Scholar

  16. Aizenberg D, Blumensohn R, Shalev A, Munitz H. Multiple exostosis, brain ventricular enlargement and schizophrenia. Psychiatr J Univ Ott. 1989; 14(1): 298-300. PubMed | Google Scholar

  17. Hanan Hamouda I, Sawasan Abdulhasan, Sadika Al-awadi. Hereditary multiple exostoses, macrocephaly, congenital heart disease, developmental delay and mental retardation in a female patient: A possible syndrome? Or new association. Egyptian Journal of Medical Human Genetics. 2011; 12(1): 95-98. PubMed | Google Scholar